Clinical Trials List
2023-12-01 - 2029-04-30
Phase III
Recruiting9
ICD-10C79.10
Secondary malignant neoplasm of unspecified urinary organs
ICD-10C79.11
Secondary malignant neoplasm of bladder
ICD-10C79.19
Secondary malignant neoplasm of other urinary organs
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9198.1
Secondary malignant neoplasm of other urinary organs
-
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/17
Investigators and Locations
Co-Principal Investigator
- Che-Yuan Hu Division of Urology
- Jui-Hung Tsai Division of Hematology & Oncology
- Yuh-Shyan Tsai Division of Urology
- Kwang-Yu Chang Division of Hematology & Oncology
- 鍾秉軒 Division of Hematology & Oncology
- Jiann-Hui Ou Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王樹吉 Division of Urology
- 洪晟鈞 Division of Urology
- 梅承恩 Division of Urology
- 楊涵中 Division of Urology
- Shian-Shiang Wang Division of Urology
- Chia-Yen Lin Division of Urology
- 張瓈文 Division of Urology
- Cheng-Kuang Yang Division of Urology
- 賴谷順 Division of Urology
- JU-CHUAN HU Division of Urology
- Cheng-Che Chen Division of Urology
- 裘坤元 Division of Urology
- 林雁婷 Division of Radiology
- 張家程 Division of Urology
- Chuan-Shu Chen Division of Urology
- 廖博崎 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林建良 Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 高婉真 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Chang Lin Division of Hematology & Oncology
- Rita cheng Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- Hong-Cheng Gan Division of Hematology & Oncology
- 張鈞弼 Division of Radiology
- Kai-Jie Yu Division of Hematology & Oncology
- PO-HUNG LIN Division of Hematology & Oncology
- See-Tong Pang Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Su-Peng Yeh Division of Hematology & Oncology
- Wei-Ching Lin Division of Radiology
- Chi-Rei Yang Division of Urology
- Hsi-Chin Wu Division of Urology
- Han Chang Division of Others -
- 蔡禮賢 Division of Urology
- Che-Hung Lin Division of Hematology & Oncology
- Chi-Ping Huang Division of Urology
- 鄭富銘 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hsiang Ying Lee Division of Urology
- 張顥瀚 Division of Urology
- Hung-Lung Ke Division of Urology
- Ching-Chia Li Division of Urology
- Sheng-Chen Wen Division of Urology
- 阮雍順 Division of Urology
- Tsu-Ming Chien Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ying-Chun Shen Division of Hematology & Oncology
- - - Division of Urology
- CHUNG-HSIN CHEN Division of Urology
- FU-JEN HSUEH Division of Hematology & Oncology
- JIAN-HUA HONG Division of Urology
- - - Division of Urology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Yeong-Shiau Pu Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
22 participants
-
Global
700 participants
